Beam stock forecast.

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ...People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Key Points. Cathie Wood is an icon in the world of disruptive tech. Her firm ARK Invest holds positions in Beam Therapeutics, COMPASS Pathways, and 908 Devices. Wall Street analysts have ...$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23)...

Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...

Find real-time SMG - Scotts Miracle-Gro Co stock quotes, company profile, news and forecasts from CNN Business.

According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.Infibeam Avenue Share Price: Find the latest news on Infibeam Avenue Stock Price. Get all the information on Infibeam Avenue with historic price charts for ...Beam Global provides sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media. It develops, patents, designs, engineers and ...(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price.

The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —. Analyst rating Based on 14 analysts giving stock ratings to BEAM in …

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...On average, analysts forecast that MSFT's EPS will be $11.13 for 2024, with the lowest EPS forecast at $10.83, and the highest EPS forecast at $11.55. On average, analysts forecast that MSFT's EPS will be $12.71 for 2025, with the lowest EPS forecast at $12.05, and the highest EPS forecast at $13.38.Key Points. Cathie Wood is an icon in the world of disruptive tech. Her firm ARK Invest holds positions in Beam Therapeutics, COMPASS Pathways, and 908 Devices. Wall Street analysts have ...Nov 29, 2023 · Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80 BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32. Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...Stock Forecast Based On a Predictive Algorithm | I Know First | Disclaimer: I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any …Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Schrodinger Inc have a median target of 47.00, with a high estimate of 80.00 and a low estimate of 29.00. The median ...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...BEEM | Complete Beam Global stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Beam Global has risen higher in 7 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%. Is Beam Global Stock Undervalued? The current Beam Global [ BEEM] share price is $6.02. The Score for BEEM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. Drug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...

Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.[LIVE] Beam Telecom share price details along with futures & options quotes. Get detailed report, 52 Week High / Low and company news on Nirmal Bang.Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Teladoc Health, Inc. (TDOC) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 22, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00. Find the latest Vertex Energy, Inc. (VTNR) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ... 0.99%. €17.62M. IBAB | Complete Ion Beam Applications S.A. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. Beam Therapeutics Let’s start off in the high-risk, high-reward biotech sector. ... (See IHRT stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit ...

The Beam Therapeutics stock forecast for tomorrow is $ 27.79, which would represent a -6.02% loss compared to the current price. In the next week, the price of BEAM is expected to decrease by -2.93% and hit $ 28.70. As far as the long-term Beam Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.

October 30, 2023 at 7:00 AM · 5 min read. Wall Street expects a year-over-year increase in earnings on lower revenues when Beam Therapeutics Inc. (BEAM) reports results for the quarter ended ...

These 4 analysts have an average price target of $48.5 versus the current price of Beam Therapeutics at $23.8, implying upside. Below is a summary of how these 4 analysts rated Beam Therapeutics ...Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSee the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Get the latest Lumber price (LBR) as well as the latest futures prices and other commodity market news at Nasdaq.Aug 13, 2023 · The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ... This morning Beam, an insurtech startup that provides dental coverage to corporate employees, announced that it has closed an $80 million Series E. Mercato-affiliated Traverse led the investment, with Nationwide insurance joining the deal. ...Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ... The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)Pricing Details. The global bridge construction market size was valued at $857.7 billion in 2020, and is projected to reach $1,416.9 billion by 2030, registering a CAGR of 5.0% from 2021 to 2030. A bridge is a super-structure that spans horizontally between supports. The major function of a bridge is to carry vertical loads.Stock Price Forecast The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ...

John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...Infibeam Avenues share price was Rs 20.15 as on 01 Dec, 2023, 03:59 PM IST. Infibeam Avenues share price was up by 0.74% based on previous share price of Rs 20.4. Infibeam Avenues share price trend: Last 1 Month: Infibeam Avenues share price moved up by 6.33%.$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend …SMM Review and Outlook of Copper and Aluminum Market in 2023-2024. Nov 29, 2023 17:35. UBS Base Metals Outlook 2024: Copper Will See A Supply Deficit, Aluminum Prices Will Be Higher Later In 2024, Lead And Zinc Will Be In Small Surplus ... LME, SHFE and COMEX copper stocks all hit multi-month low, with SHFE copper …Instagram:https://instagram. top rated futures brokers90 day tbill ratebest preferred stockswrnt stock Nov 22, 2023 · Beam Global Stock Forecast and Price Target. In recent months, notable analysts have provided yearlong price targets for Beam Global, with the average target coming in at $18.00. If it were to be achieved, this would result in a potential upside of approximately 222 percent from the most recent closing price in November, 2023. Dec 1, 2023 · Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more. best rn liability insurancesolar window stock The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46. Beam Therapeutics ( BEAM 0.68%) recently signed a major research deal with Pfizer ( PFE 0.59%) that could be worth up to $1.35 billion, and hardly anyone seemed to notice. This was clearly great ... fbs tock View the real-time BEAM price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...The global welding market size was valued at USD 23.75 billion in 2022. The market is projected to grow from USD 24.73 billion in 2023 to USD 34.18 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. The welding industry has witnessed significant technological advancements in recent years, including the development of new ...